GlassScriptPhysician profile
Christopher J Purcell
NPI 1184651838
$2,467.16
in general payments reported to CMS, 2019-2025
24 companies · $97.83 in 2025
The $97.83 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,436 · 2020: $217 · 2021: $28.50 · 2022: $140 · 2023: $190 · 2024: $357 · 2025: $97.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $544.24 | 2019-2024 | Airsupra, Farxiga |
| Amgen INC. | $227.21 | 2019-2020 | |
| Lilly USA, LLC | $193.97 | 2019-2025 | Mounjaro |
| Novo Nordisk INC | $181.60 | 2019-2020 | |
| Abbott Laboratories | $177.62 | 2023-2025 | I-Stat, Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $140.19 | 2019-2020 | |
| Dynavax Technologies Corporation | $123.84 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.92 | 2019 | |
| Sanofi-Aventis U.S. LLC | $96.15 | 2019 | |
| Allergan, INC. | $96.02 | 2019-2020 | |
| Abbvie INC. | $79.44 | 2019-2023 | |
| Amarin Pharma, INC. | $65.58 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $60.96 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $58.08 | 2019-2020 | |
| Pfizer INC. | $56.93 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $38.91 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Takeda Pharmaceuticals U.S.A., INC. | $38.05 | 2019 | |
| Gilead Sciences, INC. | $33.95 | 2019-2020 | |
| Exact Sciences Corporation | $33.90 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $31.69 | 2019 | |
| Astellas Pharma US INC | $23.95 | 2019 | |
| Arbor Pharmaceuticals, INC. | $16.73 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.03 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Purcell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.